We are pleased to announce that during the first quarter of 2019, Mushtaq Fruitwala has joined the team of Milla Pharmaceuticals Inc., the US based generics subsidiary of the Alter Pharma Group. Mushtaq will fill the position of Chief Scientific Officer and VP (US).

Mushtaq was previously associated with Perrigo plc in increasing leading and management roles and responsibilities and in the External Development Program. He was actively involved in Merger & Acquisition activities and scientific due diligence for licensing and purchase of pharmaceutical assets. Mushtaq has a Ph.D. in Technology of Pharmaceuticals and Fine Chemicals, and post-doctoral fellowships at the University of Tennessee and the University of Kentucky (USA). Mushtaq’s experience includes developing oral, parenteral and dermatological dosage forms and medical devices.